Fisher & Paykel Healthcare Corporation Limited (FPH.AX)
AUD 33.88
(-1.83%)
AUD 33.88
(-1.83%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 429.6 Million | 222.94 Million | 300.38 Million | 574.97 Million | 311.31 Million | 243.19 Million |
| Net Income | 132.6 Million | 234.27 Million | 349.11 Million | 482.01 Million | 278.28 Million | 200.85 Million |
| Depreciation & Amortization | 109.1 Million | 92.66 Million | 88.92 Million | 78.15 Million | 59.08 Million | 40.03 Million |
| Deferred income taxes | - | 4.49 Million | -6.29 Million | -54.25 Million | -23.24 Million | -3.16 Million |
| Stock-based compensation | 10.8 Million | 9 Million | 8.1 Million | 7.7 Million | 6.1 Million | 5.5 Million |
| Change in working capital | 6.9 Million | -64.76 Million | -38.44 Million | -58.38 Million | -27.41 Million | -1.24 Million |
| Other non-cash items | 170.2 Million | 206.38 Million | 123.37 Million | 342.15 Million | 170.18 Million | 91.68 Million |
| Investing Cash Flow | -339 Million | -10.57 Million | -82.9 Million | -356.12 Million | -150.81 Million | -120.68 Million |
| Investments in PPE | -339 Million | -197.77 Million | -157.28 Million | -169.83 Million | -165.34 Million | -127.97 Million |
| Acquisitions | - | - | - | - | - | 96 Thousand |
| Investment purchases | - | - | - | -186.29 Million | - | - |
| Sales/Maturities of investments | - | 187.19 Million | 74.37 Million | - | 14.52 Million | 7.2 Million |
| Other Investing Activities | -22.2 Million | 165.12 Million | 1.00 | -208.76 Million | 1.00 | 1.00 |
| Financing Cash Flow | -128.7 Million | -184.48 Million | -218.41 Million | -172.86 Million | -154.01 Million | -108.58 Million |
| Debt repayment | -30.6 Million | -9.35 Million | -92.62 Thousand | -45.3 Million | -5.03 Million | -576.05 Thousand |
| Dividends payments | -145.5 Million | -195.7 Million | -224.9 Million | -181.3 Million | -146.4 Million | -114.6 Million |
| Common Stock Repurchased | - | 921.94 Thousand | 1.03 Million | 46.12 Million | 304.32 Thousand | 1.00 |
| Common Stock Issuance | 3 Million | 2.8 Million | 2.96 Million | 3.21 Million | 2.22 Million | 288.02 Thousand |
| Other Financing Activities | -16.8 Million | 4.31 Million | -14 Million | -10.2 Million | -9.7 Million | 1.72 Million |
| Accounts receivables | -38.5 Million | -40.52 Million | 48.62 Million | -4.68 Million | -62.76 Million | -11.32 Million |
| Accounts payables | - | -17.78 Million | -5.27 Million | 60.41 Million | 45.42 Million | 16.7 Million |
| Inventory | 45.4 Million | -6.45 Million | -81.78 Million | -114.11 Million | -10.07 Million | -10.27 Million |
| Other working capital | - | -1.00 | - | 1.00 | - | 3.64 Million |
| Cash at beginning of period | 116.8 Million | 83.27 Million | 89.46 Million | 64.99 Million | 46.27 Million | 30 Million |
| Cash at end of period | 80.9 Million | 113.25 Million | 83.27 Million | 89.46 Million | 64.99 Million | 46.27 Million |
| Capital Expenditure | -339 Million | -197.77 Million | -157.28 Million | -169.83 Million | -165.34 Million | -127.97 Million |
| Effect of forex changes on cash | 2.2 Million | 2.4 Million | 200 Thousand | -1 Million | -1.2 Million | 600 Thousand |
| Net cash flow / Change in cash | -35.9 Million | 29.98 Million | -6.19 Million | 24.47 Million | 18.71 Million | 16.27 Million |
| Free Cash Flow | 90.6 Million | 25.17 Million | 143.1 Million | 405.13 Million | 145.97 Million | 115.21 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 25.3 Million | 132.6 Million | 107.3 Million | 234.27 Million | 154.4 Million | 95.9 Million |
| Depreciation & Amortization | 59.9 Million | 109.1 Million | 54.4 Million | 92.66 Million | 43.4 Million | 50.5 Million |
| Deferred income taxes | - | - | -2.04 Million | 4.49 Million | 20.87 Million | -15.29 Million |
| Stock-based compensation | 6.3 Million | 10.8 Million | 4.5 Million | 9 Million | 4.7 Million | 4.3 Million |
| Change in working capital | 13.9 Million | 6.9 Million | -7 Million | -64.76 Million | 11.8 Million | -62 Million |
| Other non-cash items | 167.7 Million | 170.2 Million | -2.7 Million | 206.38 Million | 22 Million | -86.8 Million |
| Investing Cash Flow | -63.5 Million | -339 Million | -275.5 Million | -10.57 Million | -86.5 Million | 75.2 Million |
| Investments in PPE | -52.9 Million | -339 Million | -263.89 Million | -197.77 Million | -75.8 Million | -112 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 187.19 Million | - | 174.75 Million |
| Other Investing Activities | -10.6 Million | -22.2 Million | -11.6 Million | 165.12 Million | -10.7 Million | 187.2 Million |
| Financing Cash Flow | -194.7 Million | -128.7 Million | 66 Million | -184.48 Million | -89.6 Million | -107.5 Million |
| Debt repayment | - | -30.6 Million | -146.5 Million | -9.35 Million | -16.37 Million | -20.8 Million |
| Dividends payments | -63.8 Million | -145.5 Million | -81.7 Million | -195.7 Million | -65.8 Million | -129.9 Million |
| Common Stock Repurchased | - | - | - | 921.94 Thousand | - | 48.05 Million |
| Common Stock Issuance | - | 3 Million | 1.11 Million | 2.8 Million | 1.31 Million | 1.39 Million |
| Other Financing Activities | -130.9 Million | -16.8 Million | 1.2 Million | 4.31 Million | -23.8 Million | 1.6 Million |
| Accounts receivables | -25.8 Million | -38.5 Million | -12.7 Million | -40.52 Million | -20.8 Million | -22.5 Million |
| Accounts payables | - | - | 186.35 Thousand | -17.78 Million | 3.08 Million | -19.48 Million |
| Inventory | 39.7 Million | 45.4 Million | 5.7 Million | -6.45 Million | 32.6 Million | -39.5 Million |
| Other working capital | - | - | 1.00 | -1.00 | - | -1.00 |
| Cash at beginning of period | 64.59 Million | 116.8 Million | 113.25 Million | 83.27 Million | 60.8 Million | 83.27 Million |
| Cash at end of period | 80.89 Million | 80.9 Million | 64.59 Million | 113.25 Million | 113.25 Million | 60.8 Million |
| Capital Expenditure | -52.9 Million | -339 Million | -263.89 Million | -197.77 Million | -75.8 Million | -112 Million |
| Effect of forex changes on cash | 1.4 Million | 2.2 Million | 800 Thousand | 2.4 Million | -4.2 Million | 6.6 Million |
| Net cash flow / Change in cash | 16.3 Million | -35.9 Million | -48.65 Million | 29.98 Million | 52.45 Million | -22.47 Million |
| Free Cash Flow | 220.2 Million | 90.6 Million | -107.39 Million | 25.17 Million | 160.5 Million | -110.1 Million |
9034
NOX
3002
MPP
3624
MEDICO